Cite

    Tenenbaum, A. et al. (2010). Very-low-strength evidence suggests that combining ezetimibe or fibrate with statins is no more effective than high-dose statin monotherapy for reducing all-cause mortality. Evidence-based medicine. 15 (2), pp. 52-53. [Online].